Cited by 113Infective Endocarditis Diagnosis and ManagementAntibiotic Resistance in BacteriaAntimicrobial Resistance in Staphylococcus

Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral Linezolid

Babcock, H. M., Ritchie, D. J., Christiansen, E., Starlin, R., Little, R., Stanley, S.·2001·Clinical Infectious Diseases

Abstract

We report a case of vancomycin-resistant Enterococcus faecium endocarditis that failed to respond to sequential monotherapy with chloramphenicol and quinupristin/dalfopristin but was successfully treated with oral linezolid.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/319986

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [7]7. Matsumara S, Simor E. Treatment of endocarditis with vancomycinresistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination. Clin Infect Dis 1998 ; 27:1554-6.

Cited by

Sorted by citations

Authors
Babcock, H. M., Ritchie, D. J., Christiansen, E., Starlin, R., Little, R., & Stanley, S.
Affiliations
  • Washington University in St. Louis (US)
  • Barnes-Jewish Hospital (US)
Corresponding author
Babcock, H. M.
Venue
Clinical Infectious Diseases
Published
2001-05-01
Volume
32
Issue
9
Pages
1373-1375
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2106927934
Cited by
113
References
11
Citations by year
2026: 1 · 2025: 3 · 2024: 1 · 2022: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 5 · 2014: 1 · 2013: 1 · 2012: 5
FWCI
8.36
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
vancomycin-resistant Enterococcus faecium, infective endocarditis, chloramphenicol, quinupristin/dalfopristin, antibiotic treatment failure
MeSH terms
Linezolid, Acetamides, Administration, Oral, Adult, Anti-Bacterial Agents, Endocarditis, Bacterial, Female, Follow-Up Studies, Humans, Treatment Outcome, Gram-Positive Bacterial Infections, Enterococcus faecium, Vancomycin Resistance, Oxazolidinones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review